Literature DB >> 15140032

HLA-DQ relative risks for coeliac disease in European populations: a study of the European Genetics Cluster on Coeliac Disease.

P Margaritte-Jeannin1, M C Babron, M Bourgey, A S Louka, F Clot, S Percopo, I Coto, J P Hugot, H Ascher, L M Sollid, L Greco, F Clerget-Darpoux.   

Abstract

Coeliac disease is an enteropathy due to an intolerance to gluten. The association between HLA-DQ genes and CD is well established. The majority of patients carry the HLA-DQ heterodimer encoded by DQA1*05/DQB1*02, either in cis or in trans. The remaining patients carry either part of the DQ heterodimer or DQA1*03-DQB1*0302. The aim of the study was to estimate the risks associated with different DQ genotypes in European populations. HLA information was available for 470 trio families from four countries: France (117), Italy (128), and Norway and Sweden (225). Five DQA1-DQB1 haplotypes were considered and control haplotype frequencies were estimated from the set of parental haplotypes not transmitted to the affected child. The possible genotypes were grouped into five genotype groups, based on the hierarchy of risk reported in the literature. A north-south gradient in the genotype group frequencies is observed in probands: homogeneity is strongly rejected between all country pairs. For each country, the relative risks associated with each genotype group were computed taking into account the control haplotype frequencies. Homogeneity of relative risks between countries was tested pairwise by maximum likelihood ratio statistics. The hypothesis of homogeneity of relative risks is rejected (P is approximately 10(-6)) for all country pairs. In conclusion, the gradient in the genotype group frequencies in probands is not only due to differences in haplotype frequencies but also due to differences in genotype relative risks in the studied populations; the relative risks associated with each DQ genotype group are different between northern and southern European countries; neither are they ordered in the same way. Copyright 2004 Blackwell Munksgaard

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15140032     DOI: 10.1111/j.0001-2815.2004.00237.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  49 in total

1.  Determination of the real effect of genes identified in GWAS: the example of IL2RA in multiple sclerosis.

Authors:  Marie-Claude Babron; Hervé Perdry; Adam E Handel; Sreeram V Ramagopalan; Vincent Damotte; Bertrand Fontaine; Bertram Müller-Myhsok; George C Ebers; Françoise Clerget-Darpoux
Journal:  Eur J Hum Genet       Date:  2011-11-16       Impact factor: 4.246

2.  Concordance, disease progression, and heritability of coeliac disease in Italian twins.

Authors:  L Nisticò; C Fagnani; I Coto; S Percopo; R Cotichini; M G Limongelli; F Paparo; S D'Alfonso; M Giordano; C Sferlazzas; G Magazzù; P Momigliano-Richiardi; L Greco; M A Stazi
Journal:  Gut       Date:  2005-12-14       Impact factor: 23.059

Review 3.  Celiac disease: risk assessment, diagnosis, and monitoring.

Authors:  Mala Setty; Leonardo Hormaza; Stefano Guandalini
Journal:  Mol Diagn Ther       Date:  2008       Impact factor: 4.074

4.  Overrepresentation of HLA-DQ2 in small intestinal neuroendocrine tumor patients.

Authors:  Kalle Landerholm; Ursula Falkmer; Roland Persson; Najme Wall; Claes Hallert; Johannes Järhult
Journal:  J Gastrointest Cancer       Date:  2014-12

5.  Celiac disease and HLA in a Bedouin kindred.

Authors:  Elise Eller; Pnina Vardi; Sunanda R Babu; Teodorica L Bugawan; Henry A Erlich; Liping Yu; Pamela R Fain
Journal:  Hum Immunol       Date:  2006-09-18       Impact factor: 2.850

6.  Prevalence of Adult Celiac Disease in India: Regional Variations and Associations.

Authors:  B S Ramakrishna; Govind K Makharia; Kamal Chetri; Sangitanjan Dutta; Prashant Mathur; Vineet Ahuja; Ritvik Amarchand; Ramadass Balamurugan; Sudipta D Chowdhury; Dolly Daniel; Anup Das; Gemlyn George; Siddhartha Datta Gupta; Anand Krishnan; Jasmin H Prasad; Gurvinder Kaur; Srinivasan Pugazhendhi; Anna Pulimood; Kartik Ramakrishna; Anil K Verma
Journal:  Am J Gastroenterol       Date:  2016-01-05       Impact factor: 10.864

7.  Origin of celiac disease: how old are predisposing haplotypes?

Authors:  Giovanni Gasbarrini; Olga Rickards; Cristina Martínez-Labarga; Elsa Pacciani; Filiberto Chilleri; Lucrezia Laterza; Giuseppe Marangi; Franco Scaldaferri; Antonio Gasbarrini
Journal:  World J Gastroenterol       Date:  2012-10-07       Impact factor: 5.742

8.  Symptom positivity is essential for omitting biopsy in children with suspected celiac disease according to the new ESPGHAN guidelines.

Authors:  Jiri Nevoral; Radana Kotalova; Ondrej Hradsky; Vera Valtrova; Kristyna Zarubova; Jan Lastovicka; Eva Neubertova; Marketa Trnkova; Jiri Bronsky
Journal:  Eur J Pediatr       Date:  2013-11-15       Impact factor: 3.183

9.  HLA genotyping in pediatric celiac disease patients.

Authors:  Biljana Stanković; Nedeljko Radlović; Zoran Leković; Dragana Ristić; Vladimir Radlović; Gordana Nikčević; Nikola Kotur; Ksenija Vučićević; Tatjana Kostić; Sonja Pavlović; Branka Zukic
Journal:  Bosn J Basic Med Sci       Date:  2014-08-16       Impact factor: 3.363

10.  Diabetes-specific HLA-DR-restricted proinflammatory T-cell response to wheat polypeptides in tissue transglutaminase antibody-negative patients with type 1 diabetes.

Authors:  Majid Mojibian; Habiba Chakir; David E Lefebvre; Jennifer A Crookshank; Brigitte Sonier; Erin Keely; Fraser W Scott
Journal:  Diabetes       Date:  2009-04-28       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.